Close
Achema middle east
swop processing & packaging

Apricus, Abbott strike deal to commercialize Vitaros in Canada

Note* - All images used are for editorial and illustrative purposes only and may not originate from the original news provider or associated company.

Subscribe

- Never miss a story with notifications

- Gain full access to our premium content

- Browse free from any location or device.

Media Packs

Expand Your Reach With Our Customized Solutions Empowering Your Campaigns To Maximize Your Reach & Drive Real Results!

– Access the Media Pack Now

– Book a Conference Call

– Leave Message for Us to Get Back

Related stories

Lonza Widens Cell and Gene Therapy Suite with New Products

Lonza widens cell and gene therapy suite by way...

No New Drug Submissions by the FDA With Shutdown in Place

The Food and Drug Administration (FDA), which is already...

How to Tell if Your Loved One is Developing an Addiction

Watching a loved one change in ways you do...

The Future of Balding Treatments: What’s New in 2025

Are you balding or thinning out on top? It...

Apricus Biosciences has signed a licensing deal with Abbott Laboratories, as per which Abbott will receive the exclusive rights to market Apricus Bio’s Vitaros  in Canada.

Vitaros (alprostadil), indicated to treat erectile dysfunction (ED) is applied directly as a cream that boosts blood flow.According to the collaboration deal, Abbott will commercialize and market Vitaros in Canada where the drug was approved by Health Canada in the later part of 2010.In addition, Apricus Bio will receive up to nearly $16m in up-front, regulatory and sales milestone payments, plus tiered royalty payments based on Abbott’s sales of the product in Canada.

According to the company, clinical data demonstrated that Vitaros worked in patients suffering from mild to severe ED, including men who did not respond to sildenafil citrate, while the side effects were localized and transient.

Latest stories

Related stories

Lonza Widens Cell and Gene Therapy Suite with New Products

Lonza widens cell and gene therapy suite by way...

No New Drug Submissions by the FDA With Shutdown in Place

The Food and Drug Administration (FDA), which is already...

How to Tell if Your Loved One is Developing an Addiction

Watching a loved one change in ways you do...

The Future of Balding Treatments: What’s New in 2025

Are you balding or thinning out on top? It...

Subscribe

- Never miss a story with notifications

- Gain full access to our premium content

- Browse free from any location or device.

Media Packs

Expand Your Reach With Our Customized Solutions Empowering Your Campaigns To Maximize Your Reach & Drive Real Results!

– Access theMedia Pack Now

– Book a Conference Call

– Leave Message for Us to Get Back

Translate »